Cost implications of alternative treatments for aids patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin b-based therapies
- 1 July 1991
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 23 (1) , 17-31
- https://doi.org/10.1016/0163-4453(91)93975-i
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Infections withCryptococcus neoformansin the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989
- Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patientsThe American Journal of Medicine, 1988
- Cryptococcal Meningitis in Patients with AIDSThe Journal of Infectious Diseases, 1988
- Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitisAntimicrobial Agents and Chemotherapy, 1988
- AIDS: counting the cost.BMJ, 1987
- Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitisThe American Journal of Medicine, 1987
- Cryptococcal infections in patients with acquired immune deficiency syndromeThe American Journal of Medicine, 1986
- Physician ratings of appropriate indications for six medical and surgical procedures.American Journal of Public Health, 1986
- Consensus methods: characteristics and guidelines for use.American Journal of Public Health, 1984
- Economic analysis and clinical trialsControlled Clinical Trials, 1984